Continuum Advisory »

Heron Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7k 582 2.94

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Heron Therapeutics

Rubric Capital Management
OrbiMed Advisors
Vanguard Group
BlackRock
Velan Capital Investment Management
Franklin Resources
Tejara Capital
Palisade Capital Management
Millennium Management
Adage Capital Partners GP
Geode Capital Management
Clearline Capital
D. E. Shaw & Co
State Street Corporation
Renaissance Technologies

View all funds holding Heron Therapeutics